https://www.scmp.com/rss/320463/feed en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com The world’s first new drug for treating Alzheimer’s disease in nearly two decades, based on seaweed, was approved by the Chinese government this weekend. The drug, Oligomannate, could represent a breakthrough in the global effort to develop treatments for the neurodegenerative disorder, which has no cure and is predicted to affect 150 million people worldwide by 2050. The National Medical Products Administration, China’s drug regulator, said Oligomannate had been approved for the treatment of... https://www.scmp.com/science/alzheimers-drug-oligomannate-approved-china/article/3036238?utm_source=rss_feed https://www.scmp.com/science/alzheimers-drug-oligomannate-approved-china/article/3036238?utm_source=rss_feed Mon, 04 Nov 2019 10:13:35 +0000